TY - JOUR
T1 - Feasibility of increasing the dosage of inpatient occupational therapy and physiotherapy rehabilitation via independent tasks and exercises
T2 - ‘My Therapy’
AU - Brusco, Natasha K.
AU - Tilley, Louise
AU - Walpole, Brianna
AU - Kugler, Helen
AU - Li, Ran
AU - Kennedy, Emma
AU - Morris, Meg E.
N1 - Funding Information:
Funding information This project was supported by a Cabrini Foundation Allied Health Research Grant ($10,000). The funding body has no role in the design, analysis or dissemination of the results. The authors would like to acknowledge Cabrini Health for the in-kind support that was given to this study. The authors also acknowledge the initial input to the study design by Michael Butler, Camilla Radia-George and Rosemary Higgins from Cabrini Health.
Publisher Copyright:
© 2019 Occupational Therapy Australia
PY - 2019/12
Y1 - 2019/12
N2 - Introduction: The dosage of occupational therapy and physiotherapy positively correlates with rehabilitation patient and health service outcomes. Nevertheless, increasing the dosage during inpatient rehabilitation without additional resources can be challenging. This study aimed to determine feasibility of increasing the dosage of inpatient occupational therapy and physiotherapy rehabilitation with independent tasks and exercises outside of supervised sessions, the ‘My Therapy’ programme. Methods: A two-group, quasi-experimental, pre–post-design examined feasibility of delivering My Therapy in addition to usual care, compared to usual care alone, for hospitalised musculoskeletal and frail older rehabilitation patients. My Therapy was prescribed by the occupational therapist and physiotherapist. A booklet was provided with an individually tailored set of tasks and exercises that were a sub-set of routine therapy, to be practised safely, effectively and independently outside of supervised sessions. The primary outcome was feasibility of My Therapy implementation to achieve at least 70% adherence. Secondary outcomes were self-reported daily My Therapy participation (minutes), total daily rehabilitation participation (minutes), adverse events, length of stay, 10-metre walk speed, FIM scores and discharge destination. Results: Participation in My Therapy was achieved by 72% (83/116) of the My Therapy group, who averaged 14 min (SD 14) of daily practice outside of supervised sessions. Total daily rehabilitation participation was 177 min (SD 47) for My Therapy participants (n = 116) and 148 min (SD 88) for usual care participants (n = 89); mean difference 30 min (p =.00). A minimal clinically important difference in FIM was achieved for a significantly higher portion of the My Therapy group (22%, n = 26) compared to usual care (10%, n = 9; p =.02). There were no adverse events, safety concerns or group differences for other secondary outcomes. Conclusion: My Therapy was a feasible and safe way to increase the dosage of inpatient occupational therapy and physiotherapy rehabilitation via independent practice. Clinical Trial Registry: ACTRN12616000691448.
AB - Introduction: The dosage of occupational therapy and physiotherapy positively correlates with rehabilitation patient and health service outcomes. Nevertheless, increasing the dosage during inpatient rehabilitation without additional resources can be challenging. This study aimed to determine feasibility of increasing the dosage of inpatient occupational therapy and physiotherapy rehabilitation with independent tasks and exercises outside of supervised sessions, the ‘My Therapy’ programme. Methods: A two-group, quasi-experimental, pre–post-design examined feasibility of delivering My Therapy in addition to usual care, compared to usual care alone, for hospitalised musculoskeletal and frail older rehabilitation patients. My Therapy was prescribed by the occupational therapist and physiotherapist. A booklet was provided with an individually tailored set of tasks and exercises that were a sub-set of routine therapy, to be practised safely, effectively and independently outside of supervised sessions. The primary outcome was feasibility of My Therapy implementation to achieve at least 70% adherence. Secondary outcomes were self-reported daily My Therapy participation (minutes), total daily rehabilitation participation (minutes), adverse events, length of stay, 10-metre walk speed, FIM scores and discharge destination. Results: Participation in My Therapy was achieved by 72% (83/116) of the My Therapy group, who averaged 14 min (SD 14) of daily practice outside of supervised sessions. Total daily rehabilitation participation was 177 min (SD 47) for My Therapy participants (n = 116) and 148 min (SD 88) for usual care participants (n = 89); mean difference 30 min (p =.00). A minimal clinically important difference in FIM was achieved for a significantly higher portion of the My Therapy group (22%, n = 26) compared to usual care (10%, n = 9; p =.02). There were no adverse events, safety concerns or group differences for other secondary outcomes. Conclusion: My Therapy was a feasible and safe way to increase the dosage of inpatient occupational therapy and physiotherapy rehabilitation via independent practice. Clinical Trial Registry: ACTRN12616000691448.
KW - activities of daily living
KW - exercise therapy
KW - occupational therapy
KW - physiotherapists
KW - rehabilitation
UR - http://www.scopus.com/inward/record.url?scp=85074008515&partnerID=8YFLogxK
U2 - 10.1111/1440-1630.12614
DO - 10.1111/1440-1630.12614
M3 - Article
C2 - 31602693
AN - SCOPUS:85074008515
SN - 1440-1630
VL - 66
SP - 739
EP - 752
JO - Australian Occupational Therapy Journal
JF - Australian Occupational Therapy Journal
IS - 6
ER -